11/08/2016 - 06:16

Dog cancer specialist to provide hope for terminal dogs with Pharmaust drug

11/08/2016 - 06:16

Bookmark

Save articles for future reference.

ASX listed biotech company PharmAust today announced that a leading veterinary specialist would conduct more canine trials with its promising anti-cancer drug "MP"L. NSW-based dog cancer specialist, Dr Angela Frimberger, will evaluate MPL either as a monotherapy or in conjunction with chemotherapy in dogs that have not responded to standard cancer treatments.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options